This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aribio Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Du Jin Seol: Innovator in Lipid Nanomaterials
Introduction: Du Jin Seol is a prominent inventor based in Uiwang-si, South Korea. He has made significant contributions to the field of lipid nanomaterials, particularly in the development of innovative pharmaceutical agents. His work focuses on addressing critical health issues through advanced materials and methods.
Latest Patents: Du Jin Seol holds a patent for a lipid nanomaterial containing lysophosphatidylcholine or a derivative thereof. The patent describes a method for preparing this lipid nanomaterial, which can be utilized to reduce erythrocyte lysis and hemagglutination. This invention is particularly relevant for treating septicemia and bacterial infections, showcasing its potential as a valuable therapeutic agent.
Career Highlights: Throughout his career, Du Jin Seol has been associated with Aribio Co., Ltd., where he has been instrumental in advancing research and development in lipid nanotechnology. His innovative approach has led to breakthroughs that could significantly impact the pharmaceutical industry.
Collaborations: Du Jin Seol has worked alongside notable colleagues, including Jai Jun Choung and Myung Hwa Kim. Their collaborative efforts have contributed to the success of various projects and innovations within their field.
Conclusion: Du Jin Seol's work in lipid nanomaterials exemplifies the intersection of innovation and healthcare. His contributions are paving the way for new treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile